P. Angulo, Nonalcoholic Fatty Liver Disease, New England Journal of Medicine, vol.346, issue.16, pp.1221-1252, 2002.
DOI : 10.1056/NEJMra011775

S. Hubscher, Histological assessment of non-alcoholic fatty liver disease, Histopathology, vol.82, issue.5, pp.450-65, 2006.
DOI : 10.1309/EY72-F1EN-9XCB-1KXX

S. Park, P. Kim, K. Kim, S. Lee, S. Yoon et al., Macrovesicular Hepatic Steatosis in Living Liver Donors: Use of CT for Quantitative and Qualitative Assessment, Radiology, vol.239, issue.1, pp.105-117, 2006.
DOI : 10.1148/radiol.2391050361

S. Barrington, N. Mikhaeel, L. Kostakoglu, M. Meignan, M. Hutchings et al., Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group, Journal of Clinical Oncology, vol.32, issue.27, pp.3048-58, 2014.
DOI : 10.1200/JCO.2013.53.5229

S. Barrington and R. Kluge, FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas, European Journal of Nuclear Medicine and Molecular Imaging, vol.89, issue.s5, 2017.
DOI : 10.1016/j.ijrobp.2013.05.005
URL : https://link.springer.com/content/pdf/10.1007%2Fs00259-017-3690-8.pdf

N. Paquet, A. Albert, J. Foidart, and R. Hustinx, Within-patient variability of (18)F-FDG: standardized uptake values in normal tissues, J Nucl Med: Off Publ Soc Nucl Med, vol.45, pp.784-792, 2004.

K. Kamimura, S. Nagamachi, H. Wakamatsu, R. Higashi, M. Ogita et al., Associations between liver 18F fluoro-2-deoxy-d-glucose accumulation and various clinical parameters in a Japanese population: influence of the metabolic syndrome, Annals of Nuclear Medicine, vol.112, issue.3, pp.157-61, 2010.
DOI : 10.1172/JCI200525102

R. Webb, E. Landau, D. Klein, J. Dipoce, D. Volkin et al., Effects of varying serum glucose levels on 18F-FDG biodistribution, Nuclear Medicine Communications, vol.36, issue.7, pp.717-738, 2015.
DOI : 10.1097/MNM.0000000000000319

N. Aide, C. Desmonts, J. Beauregard, T. Beyer, K. Kinross et al., High throughput static and dynamic small animal imaging using clinical PET/CT: potential preclinical applications, European Journal of Nuclear Medicine and Molecular Imaging, vol.176, issue.Suppl 2, pp.991-1001, 2010.
DOI : 10.1007/s00259-008-0984-x

N. Aide, C. Lasnon, P. Veit-haibach, T. Sera, B. Sattler et al., EANM/EARL harmonization strategies in PET quantification: from daily practice to multicentre oncological studies, European Journal of Nuclear Medicine and Molecular Imaging, vol.45, issue.Suppl 1, 2017.
DOI : 10.1053/j.semnuclmed.2014.12.001
URL : https://hal.archives-ouvertes.fr/inserm-01856095

M. Meignan, A. Gallamini, C. Haioun, S. Barrington, E. Itti et al., Report on the 5th international workshop on positron emission tomography in lymphoma held, pp.19-20

, Leuk Lymphoma, vol.56, pp.1229-1261, 2014.

S. Bellentani, G. Saccoccio, F. Masutti, L. Croce, G. Brandi et al., Prevalence of and Risk Factors for Hepatic Steatosis in Northern Italy, Annals of Internal Medicine, vol.132, issue.2, pp.112-119, 2000.
DOI : 10.7326/0003-4819-132-2-200001180-00004

V. Catenacci, J. Hill, and H. Wyatt, The Obesity Epidemic, Clinics in Chest Medicine, vol.30, issue.3, pp.415-444, 2009.
DOI : 10.1016/j.ccm.2009.05.001

A. Chiaravalloti, R. Danieli, P. Abbatiello, D. Pietro, B. Travascio et al., Factors affecting intrapatient liver and mediastinal blood pool 18F-FDG standardized uptake value changes during ABVD chemotherapy in Hodgkin???s lymphoma, European Journal of Nuclear Medicine and Molecular Imaging, vol.32, pp.1123-1155, 2014.
DOI : 10.1007/s11307-008-0177-9

G. Keramida, J. Potts, J. Bush, S. Dizdarevic, and A. Peters, Hepatic steatosis is associated with increased hepatic FDG uptake, European Journal of Radiology, vol.83, issue.5, pp.751-756, 2014.
DOI : 10.1016/j.ejrad.2014.01.027

C. Lin, W. Lin, C. Lin, C. Shih, L. Jeng et al., The negative impact of fatty liver on maximum standard uptake value of liver on FDG PET, Clinical Imaging, vol.35, issue.6, pp.437-478, 2011.
DOI : 10.1016/j.clinimag.2011.02.005

J. Abele and C. Fung, Effect of Hepatic Steatosis on Liver FDG Uptake Measured in Mean Standard Uptake Values, Radiology, vol.254, issue.3, pp.917-941, 2010.
DOI : 10.1148/radiol.09090768

N. Chalasani, Z. Younossi, J. Lavine, A. Diehl, E. Brunt et al., The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association, American College of Gastroenterology, and the American Gastroenterological Association, pp.2005-2028, 2012.
DOI : 10.1161/CIRCULATIONAHA.105.169404

D. Groheux, M. Delord, D. Rubello, P. Colletti, M. Nguyen et al., Variation of Liver SUV on 18FDG-PET/CT Studies in Women With Breast Cancer, Clinical Nuclear Medicine, vol.38, issue.6, pp.422-427, 2013.
DOI : 10.1097/RLU.0b013e3182872f0e

C. Lin, H. Ding, C. Lin, C. Chen, S. Sun et al., Impact of age on FDG uptake in the liver on PET scan, Clinical Imaging, vol.34, issue.5, pp.348-50, 2010.
DOI : 10.1016/j.clinimag.2009.11.003

D. Rubello, P. Gordien, C. Morliere, M. Guyot, L. Bordenave et al., Variability of Hepatic 18F-FDG Uptake at Interim PET in Patients With Hodgkin Lymphoma, Clinical Nuclear Medicine, vol.40, issue.8, pp.405-415, 2015.
DOI : 10.1097/RLU.0000000000000828

R. Boellaard, R. Delgado-bolton, W. Oyen, F. Giammarile, K. Tatsch et al., FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0, European Journal of Nuclear Medicine and Molecular Imaging, vol.28, issue.10, pp.328-54, 2015.
DOI : 10.1097/MNM.0b013e3282eff2d5

M. Martelli, L. Ceriani, E. Zucca, P. Zinzani, A. Ferreri et al., F]Fluorodeoxyglucose Positron Emission Tomography Predicts Survival After Chemoimmunotherapy for Primary Mediastinal Large B-Cell Lymphoma: Results of the International Extranodal Lymphoma Study Group IELSG-26 Study, Journal of Clinical Oncology, vol.32, issue.17, pp.1769-75, 2014.
DOI : 10.1200/JCO.2013.51.7524

P. Johnson, M. Federico, A. Kirkwood, A. Fossa, L. Berkahn et al., Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin???s Lymphoma, New England Journal of Medicine, vol.374, issue.25, pp.2419-2448, 2016.
DOI : 10.1056/NEJMoa1510093